BioMarin Pharmaceuticals
BMRN
BMRN
550 hedge funds and large institutions have $10.4B invested in BioMarin Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 209 increasing their positions, 161 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 536 → 550 (+14)
2.51% less ownership
Funds ownership: 97.96% → 95.45% (-2.5%)
7% less capital invested
Capital invested by funds: $11.2B → $10.4B (-$817M)
Holders
550
Holding in Top 10
11
Calls
$96M
Puts
$66.6M
Top Buyers
| 1 | +$184M | |
| 2 | +$101M | |
| 3 | +$79.5M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$59.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$57.7M |
Top Sellers
| 1 | -$85.6M | |
| 2 | -$67.1M | |
| 3 | -$58M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$55.7M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$50.5M |
